Clinical utility of an artificial intelligence radiomics-based tool for risk stratification of pulmonary nodules.
Journal:
JNCI cancer spectrum
Published Date:
Sep 2, 2024
Abstract
BACKGROUND: Clinical utility data on pulmonary nodule (PN) risk stratification biomarkers are lacking. We aimed to determine the incremental predictive value and clinical utility of using an artificial intelligence (AI) radiomics-based computer-aided diagnosis (CAD) tool in addition to routine clinical information to risk stratify PNs among real-world patients.